Endoscopy Unit, Humanitas Research Hospital
Rozzano, Milano, 20089, Italy
NCT Number: NCT02946840
Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) is a reliable, safe, and effective technique for obtaining samples from pancreatic masses. A new core biopsy needle has been developed by Beacon bnx® (Medtronic, Newton, MA) that allows the possibility to achieve a core for histology evaluation and the interchangibility of needle size using the same needle shelter and different needle sizes.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Rozzano, Milano, 20089, Italy
At every pass, the material will be fixed in formalin. Three passes will be done. Details of the aspirated material will be described at macroscopic evaluation by the endoscopist and then by the pathologist at macroscopic and microscopic evaluation, in order to find an interobserved agreement on the definition of the core.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 24 h
The presence of a core adequate for histological evaluation for final diagnosis
Istituto Clinico Humanitas
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06724055
Pancreatic Masses
View Trial DetailsNCT02167074
Lymph Nodes, Pancreatic Masses
Irvine, California, United States
View Trial DetailsNCT01576497
Pancreatic Masses
Seoul, South Korea
View Trial DetailsNCT01016288
Adrenal Masses, Celiac Disease
Copenhagen, Denmark
View Trial Details